BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, February 2, 2026
Home » Authors » David Ho

Articles by David Ho

Singapore's A*STAR draws pharma, academia to boost manufacturing innovations

Oct. 31, 2018
By David Ho
HONG KONG – Singapore's Agency for Science, Technology and Research (A*STAR) has initiated the Pharma Innovation Programme Singapore (PIPS) aimed at bringing together the city-state's public sector research capabilities and major global players in the pharma industry to transform the manufacturing operations and technologies of the industry for greater efficiencies.
Read More

Singapore's A*STAR draws pharma, academia to boost manufacturing innovations

Oct. 30, 2018
By David Ho
HONG KONG – Singapore's Agency for Science, Technology and Research (A*STAR) has initiated the Pharma Innovation Programme Singapore (PIPS) aimed at bringing together the city-state's public sector research capabilities and major global players in the pharma industry to transform the manufacturing operations and technologies of the industry for greater efficiencies.
Read More

Maz offers ostrich antibody IP in A*STAR collaboration targeting dengue viruses

Oct. 24, 2018
By David Ho
HONG KONG – Biotech company Maz World Ltd. is working with the Institute of Molecular and Cell Biology of Singapore's Agency for Science, Technology and Research (IMCB A*STAR) to use its ostrich antibody technology to neutralize the four serotypes of dengue viruses.
Read More

Maz offers ostrich antibody IP in A*STAR collaboration targeting dengue viruses

Oct. 23, 2018
By David Ho
HONG KONG – Biotech company Maz World Ltd. is working with the Institute of Molecular and Cell Biology of Singapore's Agency for Science, Technology and Research (IMCB A*STAR) to use its ostrich antibody technology to neutralize the four serotypes of dengue viruses.
Read More

Standards being introduced to 1,000+ med devices as price caps cause disputes in India

Oct. 11, 2018
By David Ho

Xact wins CE mark, $5M funding for its percutaneous robotics navigation system

Sep. 25, 2018
By David Ho

J&J's Depuy in hot water over faulty hip implants in India

Sep. 20, 2018
By David Ho

U.S.-Israel collaboration results in Vitalminer novel monitoring tech

Sep. 18, 2018
By David Ho

Indian rupee depreciation is a good news, bad news scenario for drugmakers

Sep. 12, 2018
By Alex Ho and David Ho
HONG KONG – Some outward-looking Indian drugmakers may be benefiting from the cheapest rupee ever, but others, which hedged their currency bets, could take a hit.
Read More

Indian rupee depreciation is a good news, bad news scenario for drugmakers

Sep. 10, 2018
By Alex Ho and David Ho
HONG KONG – Some outward-looking Indian drugmakers may be benefiting from the cheapest rupee ever, but others, which hedged their currency bets, could take a hit.
Read More
Previous 1 2 … 44 45 46 47 48 49 50 51 52 … 71 72 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 30, 2025.
  • Today's news in brief

    Briefs
    BioWorld MedTech briefs for Jan. 30, 2026.
  • Centessa’s CNT-9982 shows promise for MDD

    BioWorld Science
    Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
  • Red and blue bispecific antibodies

    First-in-class ADC targeting DEM-TXX shows high preclinical efficacy

    BioWorld Science
    Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
  • Illustration of brain with neuron receptor

    5-HT2R allosteric ligands attenuate cocaine use and seeking behavior

    BioWorld Science
    Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing